Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Available disease-modifying therapies can prevent relapses and relapse-associated worsening in people with multiple sclerosis by targeting autoimmunity through various mechanisms. However, these ...

Bucks County resident Joseph “Smiley” Terinoni was recently presented with a citation from the Pennsylvania House of ...

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Uveitis is uncommon in patients with multiple sclerosis (MS), but the link between the two entities is clearly established. While a common etiology or pathologic process remains unknown ...

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...

Aug. 23, 2024 — A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...